These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9569171)

  • 21. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease.
    Lamarche B
    Coron Artery Dis; 1998; 9(8):473-81. PubMed ID: 9847978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women.
    Piché ME; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J; Lemieux S
    Diabetes; 2005 Mar; 54(3):770-7. PubMed ID: 15734855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity.
    Vohl MC; Lamarche B; Bergeron J; Moorjani S; Prud'homme D; Nadeau A; Tremblay A; Lupien PJ; Bouchard C; Després JP
    Atherosclerosis; 1997 Feb; 128(2):183-90. PubMed ID: 9050775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.
    Quispe R; Martin SS; Jones SR
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
    Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
    Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
    Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disorders of lipid metabolism in insulin resistance].
    Müller-Wieland D; Krone W
    Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral obesity and hyperinsulinemia modulate the impact of the microsomal triglyceride transfer protein -493G/T polymorphism on plasma lipoprotein levels in men.
    St-Pierre J; Lemieux I; Miller-Felix I; Prud'homme D; Bergeron J; Gaudet D; Nadeau A; Despres JP; Vohl MC
    Atherosclerosis; 2002 Feb; 160(2):317-24. PubMed ID: 11849654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LDL subclass phenotypes and the risk factors of the insulin resistance syndrome.
    Austin MA; Selby JV
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S22-6. PubMed ID: 7550534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
    Krone W; Müller-Wieland D; Wirth H
    Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abdominal obesity as important component of insulin-resistance syndrome.
    Després JP
    Nutrition; 1993; 9(5):452-9. PubMed ID: 8286886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of fat accumulation and lipid disorders by individualized light aerobic training in human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidemia.
    Thöni GJ; Fedou C; Brun JF; Fabre J; Renard E; Reynes J; Varray A; Mercier J
    Diabetes Metab; 2002 Nov; 28(5):397-404. PubMed ID: 12461477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the prevalence of metabolic obesity and normal weight among the Polish population.
    Bednarek-Tupikowska G; Stachowska B; Miazgowski T; Krzyżanowska-Świniarska B; Katra B; Jaworski M; Kuliczkowska-Płaksej J; Jokiel- Rokita A; Tupikowska M; Bolanowski M; Jędrzejuk D; Milewicz A
    Endokrynol Pol; 2012; 63(6):447-55. PubMed ID: 23339002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity and metabolic complications: contribution of dehydroepiandrosterone and other steroid hormones.
    Tchernof A; Labrie F; Bélanger A; Després JP
    J Endocrinol; 1996 Sep; 150 Suppl():S155-64. PubMed ID: 8943799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.